TrialInvestigational new drugs2011

Oral enzastaurin in prostate cancer: a two-cohort phase II trial in patients with PSA progression in the non-metastatic castrate state and following docetaxel-based chemotherapy for castrate metastatic disease.

Robert Dreicer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.